Stocktoria
CAPRICOR THERAPEUTICS, INC. CAPR
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2002-06-04
CAPRICOR THERAPEUTICS, INC. statistics & valuation
Market cap$1.5B
P / B5.0×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | — | -191.1% | -95.6% | -1142.2% | -8549.9% |
| Net margin | — | -181.7% | -88.5% | -1116.1% | -8175.9% |
| FCF margin | — | -184.8% | -106.9% | 112.2% | -7352.3% |
| Return on assets | -29.5% | -23.7% | -37.9% | -57.9% | -48.4% |
| Return on equity | -34.4% | -27.8% | -98.6% | -246.2% | -63.8% |
| Current ratio | 9.01 | 7.77 | 1.63 | 1.82 | 8.82 |
| Revenue growth | -100.0% | -11.5% | 868.4% | 961.7% | -21.1% |
Source: SEC EDGAR filings · CIK 0001133869 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.